In higher eukaryotes, reactive oxygen species (ROS) are generated during re
spiration in mitochondria in the course of reduction of molecular oxygen as
well as by distinct enzyme systems. ROS have been implicated in the regula
tion of diverse cellular functions including defense against pathogens, int
racellular signaling, transcriptional activation, proliferation, and apopto
sis. The reduction-oxidation (redox) state of the cell is primarily a conse
quence of the precise balance between the levels of ROS and endogenous thio
l buffers present in the cell, such as glutathione and thioredoxin, which p
rotect cells from oxidative damage. Dramatic elevation of ROS, exceeding co
mpensatory changes in the level of the endogenous thiol buffers, may result
in the sustained activation of signaling pathways and expression of genes
that induce apoptosis in affected cells. Many cytotoxic drugs function sele
ctively to kill cancer cells by the abrogation of proliferative signals, le
ading to cell death, and numerous reports have demonstrated that ROS are ge
nerated following treatment with these drugs. In this review, we will summa
rize recent contributions to our understanding of the importance of cytotox
ic drug-induced modulation of cellular redox status for signaling and trans
cription leading to activation of apoptotic effector mechanisms.